Accueil › Mélanome › Californie › Orange
Essais cliniques pour Mélanome à Orange, CA
14 études pour Mélanome recherchent des participants dans et autour de Orange (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Recrutement en coursPhase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Recrutement en coursPhase 3
- St. Joseph Hospital Orange, Orange
- University of California Irvine, UCI Medical Center, Orange
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Recrutement en coursPhase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Recrutement en coursPhase 1/2
- Children's Hospital of Orange County, Orange
Project: Every Child for Younger Patients With Cancer
Recrutement en coursÉtude observationnelle
- Children's Hospital of Orange County, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Recrutement en coursPhase 1 précoce
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Recrutement en coursPhase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Recrutement en coursPhase 1/2
- University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Recrutement en coursPhase 3
- University of California Irvine Medical Center, Orange
A Study of VET3-TGI in Patients With Solid Tumors
Recrutement en coursPhase 1
- UC Irvine Health, Orange
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
Recrutement en coursPhase 2
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Orange
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recrutement en cours
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Orange
Essais pour Mélanome dans d'autres villes
- Houston, TX59 études
- New York City, NY38 études
- Los Angeles, CA34 études
- Nashville, TN33 études
- Pittsburgh, PA31 études
- Boston, MA26 études
- Philadelphia, PA23 études
- San Francisco, CA22 études
- Durham, NC21 études
- Atlanta, GA21 études
- St. Louis, MO21 études
- Salt Lake City, UT21 études
Autres études à Orange
- Cancer du poumon non à petites cellules25 études
- Cancer métastatique20 études
- Cancer colorectal16 études
- Cancer de l'ovaire16 études
- Cancer du pancréas15 études
- Cancer du sein14 études
- Cancer du poumon14 études
- Cancer de la prostate14 études
- Cancer du foie (carcinome hépatocellulaire)14 études
- Leucémie aiguë myéloïde13 études
- Cancer (tous types)13 études
- Cancer de l'estomac13 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.